ACE and chronic kidney disease: Indeed, blocking angiotensin II’s predilection for preferentially increasing efferent arteriole tone and thereby elevating intraglomerular pressure [5] has placed angiotensin converting enzyme inhibitors and angiotensin receptor blockers at the cornerstone of renal medicine in most CKD settings.